Search
for

    Sort by

    Research 181–210 of 356

    1. Alopecia universalis following interferon alfa-2b and ribavirin treatment for hepatitis C. PubMed · 2007 · 4 citations
    2. Widespread Dystrophic-Anagen Alopecia and Drug Eruption due to Usage of PEG-IFN ?-2a /Ribavirin Combination Therapy Hair therapy & transplantation · 2014 · 1 citations
    3. Robust Metformin Nanosystem Promotes Hair Growth in Androgenetic Alopecia Research · 2025
    4. Widespread and eruptive comedonal lesions with alopecia JAAD case reports · 2022
    5. Psoriasis and Hepatitis C: Improvement with Interferon 2011
    6. Hop Shoots (<i>Humulus lupulus</i>): Emerging Bioactive Components, Functional Properties, and Opportunities for Food and Bio-Industrial Applications DIET FACTOR (Journal of Nutritional & Food Sciences) · 2025
    7. Reversible alopecia universalis secondary to PEG-interferon ??-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus infection European Journal of Gastroenterology & Hepatology · 2007 · 41 citations
    8. Cover stories: 10 start-ups to watch: Liquid Light Focus on catalysts · 2015
    9. Safety and Efficacy of Nucleic Acid Polymers in Monotherapy and Combined with Immunotherapy in Treatment-Naive Bangladeshi Patients with HBeAg+ Chronic Hepatitis B Infection PLoS ONE · 2016 · 176 citations
    10. Chemotherapy-Induced Alopecia in Ovarian Cancer: Incidence, Mechanisms, and Impact Across Treatment Regimens Cancers · 2025 · 5 citations
    11. Life Sciences Discovery and Technology Highlights SLAS TECHNOLOGY · 2019
    12. Bullous Lesions at Polyethylene Glycol Interferon-alpha-2a Inoculation Site in a Hepatitis C Virus-infected Subject Acta Dermato Venereologica · 2007 · 2 citations
    13. Inhibitors of 5α -Reductase Type I in LNCaP Cells from the Roots of Angelica koreana Planta Medica · 2002 · 22 citations
    14. Reversible Alopecia Universalis During Treatment with PEG-Interferon and Ribavirin for Chronic Hepatitis C Journal of Chemotherapy · 2005 · 27 citations
    15. Cutaneous Reactions in Patients with Chronic Hepatitis C Treated with Peginterferon and Ribavirin Dermatology · 2014 · 15 citations
    16. Dermatologic Adverse Events from Cancer Treatments Springer eBooks · 2018 · 2 citations
    17. Aldesleukin Elsevier eBooks · 2015
    18. Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis Clinical Cancer Research · 2011 · 215 citations
    19. Interferon in the treatment of cutaneous T-cell lymphoma Dermatologic Therapy · 2003 · 107 citations
    20. Delivery of Tissue-Targeted Scalpels: Opportunities and Challenges for <i>In Vivo</i> CRISPR/Cas-Based Genome Editing ACS Nano · 2020 · 60 citations
    21. Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease Alimentary Pharmacology & Therapeutics · 2013 · 60 citations
    22. Squalene-Containing Nanostructured Lipid Carriers Promote Percutaneous Absorption and Hair Follicle Targeting of Diphencyprone for Treating Alopecia Areata Pharmaceutical Research · 2012 · 59 citations
    23. Autoimmunity and autoimmune co-morbidities in psoriasis Immunology · 2018 · 49 citations
    24. Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review) Oncology Reports · 2012 · 46 citations
    25. Alopecia in patients treated with molecularly targeted anticancer therapies Annals of Oncology · 2015 · 44 citations
    26. Lichen planus and other cutaneous manifestations in chronic hepatitis C: pre- and post-interferon-based treatment prevalence vary in a cohort of patients from low hepatitis C virus endemic area Journal of the European Academy of Dermatology and Venereology · 2008 · 34 citations
    27. Trichoscopic signs in systemic lupus erythematosus: a comparative study with 109 patients and 305 healthy controls Journal of the European Academy of Dermatology and Venereology · 2019 · 29 citations
    28. Medication-Induced Repigmentation of Gray Hair: A Systematic Review Skin appendage disorders · 2019 · 28 citations
    29. Psoriatic Skin Lesions Induced by Certolizumab Pegol Archives of Dermatology · 2010 · 21 citations
    30. Teriflunomide in multiple sclerosis: an update Neurodegenerative disease management · 2016 · 20 citations